Rockefeller Capital Management L.P. Cuts Stock Holdings in VanEck Pharmaceutical ETF $PPH

Rockefeller Capital Management L.P. lessened its position in VanEck Pharmaceutical ETF (NASDAQ:PPH) by 94.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 275 shares of the company’s stock after selling 4,630 shares during the quarter. Rockefeller Capital Management L.P.’s holdings in VanEck Pharmaceutical ETF were worth $28,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in PPH. Axxcess Wealth Management LLC increased its position in shares of VanEck Pharmaceutical ETF by 9.3% during the fourth quarter. Axxcess Wealth Management LLC now owns 9,885 shares of the company’s stock worth $1,020,000 after purchasing an additional 841 shares in the last quarter. Birchwood Financial Partners Inc. purchased a new position in VanEck Pharmaceutical ETF in the 4th quarter valued at $45,000. Wellington Management Group LLP acquired a new stake in VanEck Pharmaceutical ETF during the 4th quarter worth $42,134,000. Quadrature Capital Ltd acquired a new stake in VanEck Pharmaceutical ETF during the 4th quarter worth $5,040,000. Finally, EFG International AG purchased a new stake in shares of VanEck Pharmaceutical ETF during the fourth quarter worth $44,000.

VanEck Pharmaceutical ETF Stock Up 0.0%

Shares of NASDAQ PPH opened at $108.82 on Tuesday. The firm has a 50-day simple moving average of $105.14 and a 200-day simple moving average of $105.33. The stock has a market capitalization of $934.76 million, a price-to-earnings ratio of 20.21 and a beta of 0.46. VanEck Pharmaceutical ETF has a 52 week low of $81.74 and a 52 week high of $112.58.

VanEck Pharmaceutical ETF Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, July 7th. Investors of record on Wednesday, July 1st were paid a dividend of $0.6248 per share. This represents a $2.50 annualized dividend and a yield of 2.3%. The ex-dividend date of this dividend was Wednesday, July 1st.

VanEck Pharmaceutical ETF Company Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.